Page last updated: 2024-08-25

sofosbuvir and Acute-On-Chronic Liver Failure (ACLF)

sofosbuvir has been researched along with Acute-On-Chronic Liver Failure (ACLF) in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biliotti, E; De Angelis, M; Esvan, R; Franchi, C; Garbuglia, AR; Palazzo, D; Spaziante, M; Taliani, G; Volpicelli, L1
Debes, JD; Ricci, P1

Other Studies

2 other study(ies) available for sofosbuvir and Acute-On-Chronic Liver Failure (ACLF)

ArticleYear
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin.
    Infection, 2018, Volume: 46, Issue:5

    Topics: Acute-On-Chronic Liver Failure; Biomarkers; Coinfection; Drug Therapy, Combination; Fatal Outcome; Hepatitis E; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Shock, Septic; Sofosbuvir; Treatment Outcome; Viral Load

2018
Acute liver failure during hepatitis C treatment with sofosbuvir and ledipasvir.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:12

    Topics: Acute-On-Chronic Liver Failure; Aged; Antiviral Agents; Benzimidazoles; End Stage Liver Disease; Fatal Outcome; Fluorenes; Hepacivirus; Hepatitis C; Humans; Male; Sofosbuvir

2015